EUVIMEDObjevte EUVIMED
Open access

Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants

Satoshi Shinohara, Genki Yasuda, Mayuko Kasai, Nobuyuki Katsumata, Atsushi Nemoto, Atsushi Naito, Rei Sunami

Pediatric Pulmonology · 2026-08 · 61 (8)

DOI: 10.1002/ppul.71755 ↗

At a glance

Journal article in Pediatric Pulmonology, published online on 2026-07-27. Written by Satoshi Shinohara and 6 co-authors. Institution: Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan. Major MEDLINE topics: Magnesium Sulfate, Apnea, Infant, Premature, Diseases, Tocolytic Agents. 24 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

To evaluate the association between the timing of maternal magnesium sulfate (MgSO 4 ) discontinuation before delivery and the risk of apnea of prematurity (AOP) in late‐preterm twin infants.

Methods

This retrospective cohort study included 161 twin pregnancies (322 infants) delivered between 34 0/7 and 36 6/7 weeks at Yamanashi Prefectural Central Hospital (2017–2025). Infants with major anomalies or intrauterine fetal demise were excluded. The primary exposure was the interval between MgSO 4 cessation and delivery, categorized as: no exposure, < 12, 12–24, and ≥ 24 h. Two multivariable logistic regression models were constructed. Model 1 evaluated the association between any maternal MgSO 4 exposure and AOP. Model 2 further incorporated the timing of MgSO 4 discontinuation as a categorical exposure, adjusting for gestational age, chorionicity, small‐for‐gestational‐age status, sex, and 1‐min Apgar score.

Results

Among the 322 infants, 112 (34.8%) developed AOP. In Model 1, maternal MgSO 4 exposure itself was not significantly associated with AOP. However, in Model 2, delivery within 12 h after cessation of MgSO 4 was independently associated with AOP (adjusted odds ratio, 7.44; 95% confidence interval, 1.48–37.4), whereas longer discontinuation intervals (12–24 or ≥ 24 h) were not.

Conclusions

Among late‐preterm twin infants, maternal MgSO 4 exposure itself was not independently associated with AOP; however, delivery soon after MgSO 4 discontinuation was associated with an increased risk of AOP. These findings support consideration of MgSO 4 discontinuation timing in perinatal risk assessment and neonatal respiratory monitoring and may help guide future studies.

Subjects

MeSH terms (MEDLINE)

Magnesium SulfateApneaInfant, Premature, DiseasesTocolytic AgentsHumansFemaleInfant, NewbornPregnancyRetrospective StudiesInfant, PrematurePregnancy, TwinMaleGestational AgeTime FactorsAdult

Author keywords

apnea of prematuritydiscontinuation timinglate‐pretermmagnesium sulfatetwin pregnancy

Substances

Magnesium SulfateTocolytic Agents

Authors and institutions

  • Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan.
  • Department of Neonatology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan.

Cite

APA

Shinohara, S., Yasuda, G., Kasai, M., Katsumata, N., Nemoto, A., Naito, A., & Sunami, R. (2026). Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants. Pediatric Pulmonology, 61(8). https://doi.org/10.1002/ppul.71755

Vancouver

Shinohara S, Yasuda G, Kasai M, Katsumata N, Nemoto A, Naito A, et al. Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants. Pediatric Pulmonology. 2026;61(8). doi:10.1002/ppul.71755

BibTeX
@article{Shinohara2026,
  author = {Shinohara, Satoshi and Yasuda, Genki and Kasai, Mayuko and Katsumata, Nobuyuki and Nemoto, Atsushi and Naito, Atsushi and Sunami, Rei},
  title = {Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {8},
  doi = {10.1002/ppul.71755}
}
Start for free →